Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound

International Journal of Epidemiology

Volumn 25, Issue 5, 1996, Pages 953-958

  Råstam, Lennart ^a,b,f   Lindberg, Gunnar ^c   Folsom, Aaron R ^a   Burke, Gregory L ^d   Nilsson Ehle, Peter ^b   Lundblad, Arne ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LUND UNIVERSITY   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e LINKÖPING UNIVERSITY   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; B mode ultrasound; Glycoproteins; Sialic acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STROKE; ULTRASOUND;

EID: 0029910126     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.5.953     Document Type: Article

References (22)

1. Lindberg G, Eklund G A, Gullberg B, Råstam L. Serum sialic acid concentration and cardiovascular mortality. Brit Med J 1991; 302: 143-46.
2. Lindberg G, Råstam L, Gullberg B, Eklund G A. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol 1992; 21: 253-57.
3. Stuart J, George A J, Davies A J, Aukland A, Hurlow R A. Haematological stress syndrome in atherosclerosis. J Pathol 1981; 34: 464-67.
4. Lindberg G, Råstam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson B S. Serum total sialic acid and sialoprotein concentration in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123-29.
5. Heiss G, Sharrett R, Barnes R, Chambless L E, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-56.
6. Fuster V, Cheseboro JH, Frye RL, Elveback LR. Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 1981; 63: 546-51.
7. Fuster V, Badimon L, Badimon J J, Cheseboro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes. (Second of two parts). N Engl J Med 1992; 326: 242-50.
8. The ARIC Investigators. The atherosclerosis risk in communities (ARIC) study: Design and objectives. Am J Epidemiol 1989; 129: 687-702.
9. Pignoli P, Tremoli E, Poli A et al. Intimal plus medial thickness of arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
10. National Heart, Lung, and Blood Institute. ARIC manuals of operation no 6, 7, 8 and 10. Chapel Hill NC: ARIC Coordination Center, School of Public Health, University of North Carolina, 1987.
11. Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1977; 23: 60-63.
12. Jourdian G W, Dean L, Roseman S. The sialic acids. J Biol Chem 1971; 246: 430-35.
13. Breslow N E, Day N E. Statistical Methods in Cancer Research. Vol. 1. Lyon: IARC, 1980. (Scientific Publication No. 32)
14. Fahie-Wilson M, Mills R, Wilson K. HDL cholesterol and the acute phase reaction following myocardial infarction and acute pancreatitis. Clin Chim Acta 1987; 167: 197-209.
15. Pola P, Savi L. Fibrinogenemia, determined immunonephlometrically, as a possible parameter in the evaluation of peripheral atherosclerotic arteriopathy. Atherosclerosis 1978; 29: 205-16.
16. Nicolaides A N, Bowers R, Horbourne T, Kidner P H, Besterman E M. Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina. Lancet 1977; i: 943-45.
17. Ernst E, Hammerschmidt D E, Bagge U, Matrai A, Dormandy J A. Leukocytes and the risk of ischemic disease. JAMA 1987; 257: 2318-24.
18. Zalokar J B, Richard J L, Claude J R. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981; 304: 465-68.
19. Grimm R H, Neaton J D, Ludwig W. Prognostic importance of the white blood cell count for coronary heart disease, cancer and all-cause mortality. JAMA 1985; 254: 1932-37.
20. Meade T W, North W R S, Chakrabarti R, Stirling Y, Haines A P, Thompson S G. Haemostatic function and cardiovascular death: Early results of a prospective study. Lance: 1980; i: 1050-54.
21. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-05.
22. Clamp J R. Structure and functions of glycoproteins. In: Putman F W, (ed.) The Plasma Proteins. Structure, Function, and Genetic Control. New York: Academic Press, 1975.